d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
> OrganizedTime.com, a certified Virtual Assistant, you can
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
benefit from using a VA for administrative tasks (such as bill
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
ng), customer contact (follow up or reminder calls), project wo
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
rk (building or maintaining a client data base), or even person
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
al tasks (such as sending holiday cards).
You can find a VA th
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
rough personal referrals--you might be surprised how many of yo
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
ur colleagues are using VA services--or by searching online. Re
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
member that your VA doesn't have to be local. Most services can
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
be provided remotely. Do talk to VA candidates to make sure yo
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
are comfortable and can work well together.
How much will a V
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
A cost? VAs may charge a monthly retainer, or they may charge a
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
n hourly rate or project fee. Ultimately, the question is how h
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
aving a VA will impact your bottom line. If you are freed from
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
routine tasks and can devote that time to marketing, product de
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
velopment or billable hours, you will see your profits increase
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
